AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Mar 4, 2015
29828_dirs_2015-03-04_d29ea273-d7e2-4f60-8996-17df16a3f499.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-03-02
Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-02 | Common Stock | M | 10000 | $19.085 | Acquired | 159422 | Direct |
| 2015-03-02 | Common Stock | S | 8607 | $103.5874 | Disposed | 150815 | Direct |
| 2015-03-02 | Common Stock | S | 1393 | $104.2135 | Disposed | 149422 | Direct |
| 2015-03-02 | Common Stock | S | 1800 | $103.3581 | Disposed | 147622 | Direct |
| 2015-03-02 | Common Stock | S | 200 | $104.12 | Disposed | 147422 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-03-02 | Non-Qualified Stock Option (right to buy) | $19.085 | M | 10000 | Disposed | 2021-01-20 | Common Stock (10000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $103.1321 to $104.12. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $104.14 to $104.30. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5: Sale prices reported for the transactions reported here range from $102.90 to $103.76. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F6: Sale prices reported for the transactions reported here range from $104.02 to $104.22. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.